Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 101 related to Grady: Hormone therapy to prevent disease and prolong life in postmenopausal women. (0.12 sec) 

[PDF] Hormone therapy to prevent disease and prolong life in postmenopausal women


D Grady, SM Rubin, DB Petitti, CS Fox, D Black, B … - Ann Intern Med, 1992 - sjsu.edu
Table 1. Postmenopausal Hormone Use and Endometrial Cancer Reference (Year) Unopposed
Estrogen Estrogen and Progestin Ever Use Relative Risk Duration of Use Ever Use Years of
Use Relative Risk Relative Risk Case control Smith (188) (1975) 4.5* Ziel (12) (1975) ...
Cited by 1995 - Related articles - All 6 versions

Estrogen replacement therapy and coronary heart disease: a quantitative …

- oxfordjournals.org
MJ Stampfer, GA Colditz - International Journal of Epidemiology, 2004 - IEA
Considerable epidemiological evidence has accumulated regarding the effect of post-menopausal
estrogens on coronary heart disease risk. Five hospital-based case-control studies yielded inconsistent
but generally null results; however, these are difficult to interpret due to the problems in ...
Cited by 1352 - Related articles - BL Direct - All 6 versions

Postmenopausal estrogen and progestin use and the risk of cardiovascular …


F Grodstein, MJ Stampfer, JAE Manson, GA … - New England Journal …, 1996 - content.nejm.org
Methods We examined the relation between cardiovascular disease and postmenopausal hormone
therapy during up to 16 years of follow-up in 59,337 women from the Nurses' Health Study, who
were 30 to 55 years of age at base line. Information on hormone use was ascertained ...
Cited by 1174 - Related articles - BL Direct - All 15 versions

Postmenopausal estrogen therapy and cardiovascular disease: ten-year follow-up …


MJ Stampfer, GA Colditz, WC Willett, JE … - Obstetrical & …, 1992 - journals.lww.com
Menopause 135 Postmenopausal Estrogen Therapy and Cardiovascular Disease: Ten-Year
Follow-Up From the Nurses' Health Study MEIR J. STAMPFER, GRAHAM A. COLDITZ, WALTER
ะก WILLETT, JOANN E. MANSON, BERNARD ROSNER, FRANK E. SPEIZER and ...
Cited by 1722 - Related articles - All 7 versions

Randomized trial of estrogen plus progestin for secondary prevention of coronary …

- ama-assn.org [PDF] 
S Hulley, D Grady, T Bush, C Furberg, D Herrington, B … - Jama, 1998 - Am Med Assoc
You are seeing this message because your Web browser does not support basic Web
standards. Find out more about why this message is appearing and what you can do to make
your experience on this site better. ... Add to CiteULike Add to Connotea Add to ...
Cited by 4431 - Related articles - BL Direct - All 15 versions

Postmenopausal hormone therapy and mortality


F Grodstein, MJ Stampfer, GA Colditz, WC … - New England Journal …, 1997 - content.nejm.org
Methods We examined the relation between the use of postmenopausal hormones and mortality
among participants in the Nurses' Health Study, who were 30 to 55 years of age at base line
in 1976. Data were collected by biennial questionnaires beginning in 1976 and ...
Cited by 1040 - Related articles - BL Direct - All 12 versions

The use of estrogens and progestins and the risk of breast cancer in …


GA Colditz, SE Hankinson, DJ Hunter, WC … - New England Journal …, 1995 - content.nejm.org
Abstract Background. The effect of adding progestins to estrogen therapy on the risk of breast
cancer in post- menopausal women is controversial. Methods. To quantify the relation between
the use of hormones and the risk of breast cancer in postmenopaus- al women, we ...
Cited by 1294 - Related articles - BL Direct - All 11 versions

Decreased mortality in users of estrogen replacement therapy


BE Henderson, A Paganini-Hill, RK … - Archives of internal …, 1991 - archinte.highwire.org
In a prospective study of 8881 postmenopausal female dents of a retirement communityin southern
California,we ated in detail the relationship between estrogen use and overall mortality. After
71/2years of follow-up, there had been 1447 deaths. Women with a historyofestrogen use ...
Cited by 531 - Related articles - All 5 versions

Cardiovascular mortality and noncontraceptive use of estrogen in women: results …

- ahajournals.org [PDF] 
TL Bush, E Barrett-Connor, LD Cowan, MH Criqui, RB … - Circulation, 1987 - Am Heart Assoc
TRUDY L. BUSH, PH.D., MHS, ELIZABETH BARRETT-CONNOR, MD, LINDA D. COWAN,
PH.D., ... MICHAEL H. CRIQUI, MD, MPH, ROBERT B. WALLACE, MD, CM SUCHINDRAN,
PH.D., ... HA TYROLER, MD, AND BASIL M. RIFKIND, MD, FRCP
Cited by 1175 - Related articles - All 6 versions

Effects of estrogen replacement on the progression of coronary-artery …

- vcu.edu [PDF] 
DM Herrington, DM Reboussin, KB Brosnihan … - New England Journal …, 2000 - content.nejm.org
Results Estrogen and estrogen plus medroxyprogesterone acetate produced significant reductions
in low-density lipoprotein cholesterol levels (9.4 percent and 16.5 percent, respectively) and
significant increases in high-density lipoprotein cholesterol levels (18.8 percent and 14.2 ...
Cited by 1193 - Related articles - BL Direct - All 12 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google